Sichenzia Ross Friedman Ference LLP Represents Cynata on A$5.0M Private Placement

cynata therapeutics

Press Release – New York – July 17, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that acted as US counsel  to Australian-based stem cell and regenerative medicine provider Cynata Therapeutics Limited (ASX: CYP) in connection with a A$5 million private placement. The offering consisted of 6,670,000 shares of Cynata’s common stock and warrants priced at A$0.75 per share.

The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia and David Manno. H.C. Wainwright & Co. acted as the sole placement agent on the offering.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRF's LinkedIn page
Sichenzia Ross Ference LLP